The company deploys the next phase of work
Release time:
2020-07-22
Efforts to Recover the Losses Caused by the Epidemic
Company Deploys the Next Phase of Work
News 4# October 16 , 17 , the company successively held work analysis meetings for pharmaceutical sector, cement sector and directly affiliated enterprises to summarize and take stock of the gains and losses of the work in the first quarter, requirements for this year's follow-up work, especially in the second quarter. At the
analysis meeting, the heads of the enterprises reported the work situation in the first quarter, focusing on the analysis of the existing problems, and put forward solutions and improvement plans. In the first quarter of this year, due to the outbreak of the new coronavirus pneumonia epidemic, the epidemic situation and prevention and control measures vary from place to place, the Spring Festival holiday was extended, the flow of people and logistics was blocked, the market was stagnant for a long time, and all business sectors of the company were affected to varying degrees. Since the resumption of work, the subordinate enterprises in earnest to do a good job in the prevention and control of the epidemic at the same time, to overcome many difficulties in efforts to resume work and production. In particular, the Daye Peak Cement Company, which is located in the central area of the epidemic, with the help and coordination of local government departments at all levels, organized manpower, scientifically arranged processes, and carried out a comprehensive overhaul of production equipment. Guizhou Peak, Peak Pharmaceutical Internationalization, Anhui New North Card - Zhongwang Phase II and other projects under construction have also overcome many difficulties and the project construction has returned to normal progress. Since the outbreak of the epidemic, there has been no case of infection in the whole group company, the state of mind of the employees is stable, and all production and operation work has been on the right track. At the
work analysis meeting, chairman Jiang Xiaomeng, general manager Yu Jianhong and other group company leaders commented on the work of each business sector one by one based on the economic and technical data of each enterprise in the first quarter, pointed out the highlights of the work, analyzed the problems and deficiencies, and put forward guidance and work requirements on how to further improve the work quality and minimize the losses caused by the epidemic in the second three quarters of this year.
Spike Pharmaceuticals: Catch Products, Reduce Costs, Strong Marketing
The meeting pointed out that the pharmaceutical industry has strong policy relevance, high technical requirements, and subsequent changes due to the epidemic are more complex. In view of the current actual situation of Jianfeng Pharmaceutical and the changing trend of the industry after the epidemic, it is necessary to concentrate superior resources according to the company's established development strategic objectives, and solidly cultivate the enterprise's own competitive advantages; further strengthen the internal integration of the enterprise, strengthen and build a streamlined and capable workforce; continue to strengthen process reengineering, and further straighten out every link from procurement, production to organizational structure establishment; go all out to break through the "intestinal obstruction" phenomenon in the whole process of product research and development, verification, production and listing; further optimize the sales team, strengthen the planning before the launch of new products, and strive for new breakthroughs in sales; further strengthen scientific and technological innovation, speed up the construction and optimization of R & D platform; do a good job in safety and environmental protection management with a "zero tolerance" attitude, improve the safety and environmental protection management system and process, and improve the staff awareness and related skills level. The
meeting pointed out that the impact of the epidemic, the import of pharmaceutical raw materials and intermediates has been blocked, objectively bringing new development opportunities to relevant domestic enterprises. North Carolina Company and its subordinate enterprises should pay attention to the management of production, quality and safety, and strive for more market opportunities in time.
Cement Plate: Strengthen Management, Reduce Costs, Set Advantages, and Seek Development
Among the company's various industrial plates, the cement plate is most obviously affected by business conditions. With the improvement of the epidemic prevention and control situation, the production and sales of two cement enterprises, Daye Peak and Yunnan Peak, have gradually returned to normal levels, and the construction of Guizhou Peak is also progressing steadily. The meeting pointed out that the current technological progress in the cement industry is very fast, and the future development of enterprises is facing severe challenges. The peak cement sector must arm itself from the control of management, technology and resources, and strive to establish advantages in market competition. We should further do a good job in fine management, standardized management and on-site rectification. In view of the fact that the current epidemic has not been completely lifted and the market is in a recovery period, we will impose management, maintenance and further expansion. After Daye Peak carries out system transformation, it is necessary to do a good job in equipment operation management to ensure that the equipment reaches the predetermined standard as soon as possible and improve the effective operation rate; at the same time, it is necessary to strengthen communication with local government departments at all levels to strive for further development. Yunnan Jianfeng should make great efforts to do a good job in mine renovation, and at the same time strengthen technical research and equipment technical transformation, and strive to reduce production costs.
International Trading Company: clear positioning, strong management, cost control, market expansion
Conference requires international trading companies to further change their management concepts, take existing business operations as a starting point, and comprehensively improve their management level; On the basis of innovative business models, further introduce new varieties, new customers and expand new businesses; Make good use of the qualifications of non-car carriers to expand new business areas; strengthen standardized management, further optimize management processes, reduce management and operating costs, and improve profitability.
Cable Company: Flexible response to the market and strengthening internal management
Conference requires cable companies to adapt to the characteristics of small quantity, small size and high standard of the current cable market in view of the new situation inside and outside the enterprise, and adjust and establish a stable business model by establishing a broad and long-term stable customer base. Do a good job in fine, standardized management and process control to reduce production and operation costs; strengthen the flexibility of production organization, further strengthen quality control and staff skills training, reduce costs by reducing the failure rate and unnecessary loss, improve the profit space, and strive for greater benefits.
Peak Health: Plug Loopholes, Grasp Standards, and Strengthen Responsibility
In view of the current operating situation of Peak Health, the meeting required the management team to carefully analyze the current situation and market, grasp the key points, and guide the future production and operation work with new ideas and new thinking. To further strengthen the sense of responsibility of every post and every employee, establish an overall management and control system for procurement, production, inventory, and sales, and strengthen the control of the entire process of operation and management; carefully analyze the advantages of its own products and technologies, and strive to find a breakthrough in sales work, maximize profitable business, and strive to reverse the operation Dilemma. The
meeting pointed out that the new coronary pneumonia epidemic will have a significant impact on the market structure, business model, and development trends of many industries. The management teams of the company's subsidiaries should promptly grasp the market trends and develop with a long-term development perspective. Work, and strive to further improve the quality of work in the next three quarters, and complete the work goals set at the beginning of the year. (this newspaper reporter)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31